glp 1 sanofi GLP-1 Pipeline Update: February 2025 - Prime Therapeutics and natural appetite control. Sanofi considers entering obesity market

Replace gel packs every 6-12 months or whenever you notice they are not staying frozen as long as they used to

These medicines have also yielded meaningful benefits for obese individuals who were unable to achieve adequate weight reduction through lifestyle modifications

Kortepeter, Acute Cholecystitis Associated With the Use of Glucagon-Like Peptide-1 Receptor Agonists Reported to the US Food and Drug Administration, JAMA Intern

"As a convenient once-daily pill, orforglipron may provide a new option and, if approved, could be readily manufactured and launched at scale for use by people around the world," David A

Long-term maintenance with periodic re-evaluation, since obesity is a chronic condition